Join us at Chemical Computing Group (CCG) Drug Design workshops in Cambridge, UK!
On November 19 at 12PM, Peter Schmidtke, PhD, Product Owner, will participate in CCG’s Drug Design workshops to present the science and technology behind Discngine’s newest product, 3dpredict/Ab, a cloud-based SaaS platform for ensemble-based antibody structure prediction and liability property calculations.
Peter is looking forward to answering your questions and discussing your needs.